Key result
Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion strongly correlated with 201Tl activity (r=0.90, P<0.001) and showed 95% concordance for detecting myocardial viability.
Why the study?
Does Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion improve the detection of ischemic but viable myocardium compared to thallium-201 imaging in patients with CAD and LV dysfunction?
Cross-Sectional (n=50)
Does Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion improve the detection of ischemic but viable myocardium compared to thallium-201 imaging in patients with CAD and LV dysfunction?
Effect estimate: r = 0.90
p-value: p=<0.001
Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion is highly concordant with thallium-201 imaging for detecting myocardial viability in patients with CAD and LV dysfunction.
Supports Tc-99m-tetrofosmin-nitroglycerin as potential 201Tl alternative for viability; leaves open prospective validation in CAD with LV dysfunction.
The aim of this study was to assess the influence of incremental nitroglycerin infusion (NTG+Inf) on the myocardial uptake of 99mTc-tetrofosmin (TF) in order to determine whether nitrates enhance the detection of viable myocardium with TF in patients with coronary artery disease (CAD) and left ventricular dysfunction. Fifty patients (39 males, 11 females; 54 +/- 11 years) with previous myocardial infarction and left ventricular dysfunction, who had been referred for coronary revascularization procedures, were studied. Myocardial single-photon emission tomography (SPET) images were obtained 1 h after injection of 750 MBq TF at baseline and after NTG+Inf, using a 2 day protocol. NTG+Inf was performed starting at 0.4 microg x kg(-1) x min(-1), with equal increments every 5 min up to 2 microg x kg(-1) x min(-1). Within 1 week of the TF study, rest-redistribution (R-RD) 201Tl SPET was performed after the injection of 111 MBq 201Tl. For each study, quantitative analysis was performed in 17 segments. Viability was defined as the presence of tracer uptake of > 50% of the peak activity on baseline studies or reversibility. There was significant correlation between quantitative regional RD 201Tl activity and TF activity after NTG+Inf (r = 0.90, P < 0.001). Of the 131 segments with severely reduced tracer uptake on resting TF images, 34 (26%) were reversible, showing increased tracer uptake after NTG+Inf (from 41%+/-7% to 57%+/-12% of peak activity; P < 0.001). All reversible segments after NTG+Inf had viability criteria on 201Tl studies. There was 95% concordance between TF with NTG+Inf and RD 201Tl imaging with regard to the presence of myocardial viability. We conclude that TF imaging with incremental NTG+Inf improves the detection of ischaemic but viable myocardium, correlating with the viability criteria observed on 201Tl studies. When the advantages of TF imaging are considered, rest TF imaging with NTG+Inf may be a practical diagnostic protocol in patients with CAD and left ventricular dysfunction who are being considered for revascularization.
No takes yet. Share an insight, caveat, or question.
Kula et al. (2003) conducted a cross-sectional in coronary artery disease and left ventricular dysfunction (n=50). Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion vs. rest-redistribution 201Tl SPET was evaluated on Correlation between quantitative regional RD 201Tl activity and TF activity after NTG+Inf (r = 0.90, p=<0.001). Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion strongly correlated with 201Tl activity (r=0.90, P<0.001) and showed 95% concordance for detecting myocardial viability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: